Use of High Dose Radiation Followed by Chemotherapy and Radiation to Treat Locally Advanced NSCLC
Status:
Recruiting
Trial end date:
2026-05-01
Target enrollment:
Participant gender:
Summary
This is a single-arm, single-stage Phase II study designed to evaluate the 1-year PFS rate in
subjects with locally-advanced NSCLC (stage II/III) and treated with Stereotactic Body
Radiation Therapy (SBRT) followed by concurrent mediastinal chemoradiation with or without
consolidation chemotherapy. A total of 60 subjects will be enrolled to this study over a 4
year accrual period.